The SVA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SVA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SVA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SVA Detailed Price Forecast - CNN Money||View SVA Detailed Summary - Google Finance|
|View SVA Detailed Summary - Yahoo! Finance||View SVA Stock Research & Analysis - Zacks.com|
|View SVA Trends & Analysis - Trade-Ideas||View SVA Major Holders - Barrons|
|View SVA Call Transcripts - NASDAQ||View SVA Breaking News & Analysis - Seeking Alpha|
|View SVA Annual Report - CompanySpotlight.com||View SVA OTC Short Report - OTCShortReport.com|
|View SVA Fundamentals - TradeKing||View SVA SEC Filings - Bar Chart|
|View Historical Prices for SVA - The WSJ||View Performance/Total Return for SVA - Morningstar|
|View the Analyst Estimates for SVA - MarketWatch||View the Earnings History for SVA - CNBC|
|View the SVA Earnings - StockMarketWatch||View SVA Buy or Sell Recommendations - MacroAxis|
|View the SVA Bullish Patterns - American Bulls||View SVA Short Pain Metrics - ShortPainBot.com|
|View SVA Stock Mentions - StockTwits||View SVA Stock Mentions - PennyStockTweets|
|View SVA Stock Mentions - Twitter||View SVA Investment Forum News - Investor Hub|
|View SVA Stock Mentions - Yahoo! Message Board||View SVA Stock Mentions - Seeking Alpha|
|View Insider Transactions for SVA - SECform4.com||View Insider Transactions for SVA - Insider Cow|
|View SVA Major Holdings Summary - CNBC||View Insider Disclosure for SVA - OTC Markets|
|View Insider Transactions for SVA - Yahoo! Finance||View Institutional Holdings for SVA - NASDAQ|
|View SVA Stock Insight & Charts - FinViz.com||View SVA Investment Charts - StockCharts.com|
|View SVA Stock Overview & Charts - BarChart||View SVA User Generated Charts - Trading View|
Sinovac Raises $86.73 Million Through Private Placement Transaction
Posted on Tuesday July 03, 2018
BEIJING, July 3, 2018 /PRNewswire/ --Sinovac Biotech Ltd. (SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has completed a private placement of its common shares (a "private investment in public equity," or "PIPE") with private investors Vivo Capital and Advantech Capital. Sinovac will receive gross proceeds of $86.73 million. The proceeds will be used to increase the Company's capabilities in research relating to quality control and to build additional production facilities to support the development and commercialization of sIPV-based combination vaccine and other new vaccine projects.
Sinovac Files Motion for Summary Judgment on Rights Agreement in Delaware Chancery Court
Posted on Tuesday June 26, 2018
BEIJING, June 26, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has filed a motion for partial summary judgment in Delaware Chancery Court. The motion introduces recently obtained information showing that the Sinobioway Consortium, led by Sinobioway Biomedicine Co., Ltd. ("Sinobioway"), a minority shareholder of the Company's controlled Chinese subsidiary, Sinovac Biotech Co., Ltd. ("Sinovac Beijing"), and a group of Sinovac's shareholders led by 1Globe and OrbiMed (the "Dissident Shareholders") reached an agreement, arrangement or understanding before the Company's annual general meeting held on February 6, 2018 (the "AGM"). Prior to the AGM, the Sinobioway Consortium and the Dissident Shareholders agreed to appear at the AGM to nominate and to vote for new directors controlled by Sinobioway or the Dissident Shareholders.
Is Sinovac Biotech Ltd’s (NASDAQ:SVA) PE Ratio A Signal To Buy For Investors?
Posted on Tuesday June 12, 2018
Sinovac Biotech Ltd (NASDAQ:SVA) trades with a trailing P/E of 18.8x, which is lower than the industry average of 27.5x. While this makes SVA appear like a great stock toRead More...
Sinovac Biotech Relaunches Company Website
Posted on Monday June 11, 2018
BEIJING , June 11, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced ...